Archer-Daniels-Midland Company
Clinical trials sponsored by Archer-Daniels-Midland Company, explained in plain language.
A global food processing and commodities trading corporation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Gut check: do probiotics or postbiotics help during antibiotics? Results expected May 2027 (estimated)
- Can a chewable postbiotic tablet keep plaque and gum inflammation at bay? Results expected Jun 2027 (estimated)
-
Can a chewable postbiotic tablet keep plaque and gum inflammation at bay?
Prevention Not yet recruitingResearchers are testing whether a chewable postbiotic tablet, taken twice daily after brushing, affects plaque buildup, gum inflammation, and the mix of bacteria in the mouth. The trial enrolls 56 healthy adults aged 18 to 65 who pause their usual brushing and flossing for a shor…
Sponsor: The Archer-Daniels-Midland Company • Aim: Prevention
Last updated Sep 21, 2026 22:00 UTC
-
Gut check: do probiotics or postbiotics help during antibiotics?
Knowledge-focused Not yet recruitingThis study tests whether taking a probiotic (live bacteria) or a postbiotic (heat-inactivated bacteria) can keep the gut microbiome healthy while people take antibiotics. About 126 healthy adults will receive one of these supplements or a placebo daily for 28 days. Researchers wi…
Sponsor: The Archer-Daniels-Midland Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC